Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
AECI Ltd (AFE.JO)
Sandton, ZA
AECI Ltd, a diversified South African-based enterprise with a global footprint, provides solutions across a broad spectrum of industries. These include mining, water management, agricultural and animal health, food and beverage production, infrastructure development, and general industrial sectors. Its international presence spans Africa, Europe, Southeast Asia, the Americas (North and South), and Australia. The company organizes its extensive operations into five primary divisions: AECI Mining, AECI Water, AECI Agri Health, AECI Chemicals, and AECI Property Services & Corporate. AECI Mining offers comprehensive "mine-to-mineral" services for the extractive industry, which include commercial explosives, initiation technologies, expert blasting services, and specific surfactants used in explosive manufacturing. AECI Water is dedicated to integrated water treatment and process solutions, providing specialized chemicals and equipment for various applications like public and industrial water systems, desalination facilities, and utility operations. AECI Agri Health focuses on the agricultural and animal well-being sectors, producing and distributing crop protection agents, plant fertilizers, animal feed premixes, unique animal health formulations, and fine chemicals. AECI Chemicals serves as a key supplier of essential raw materials and related services to clients within the food and beverage, general manufacturing, road construction, and wider industrial sectors. Lastly, AECI Property Services & Corporate manages property leasing and comprehensive management services for office, industrial, and retail properties. Founded in 1894, the company maintains its headquarters in Sandton, South Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.86% | +1.34% | +12.07% | +12.89% | +40.31% | +38.65% | +19.86% | +48.35% | +21.77% | +38.71% | +883.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-4.2% Q4'25: -13.6% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+226.5% ★ Q4'25: -90.1% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.2% ★ Q4'25: +9.1% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+7.4% Q4'25: +8.1% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+12.2% ★ Q4'25: +27.4% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+1.1% Q4'25: -3.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.40× ★ Q4'25: 0.65× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
18.45B
est: 18.43B (+0.1%)
|
18.60B
est: 19.31B (-3.7%)
|
18.48B
est: 18.37B (+0.6%)
|
23.31B
est: 23.21B (+0.5%)
|
24.80B
est: 25.44B (-2.5%)
|
24.11B
est: 26.89B (-10.3%)
|
26.05B
est: 28.06B (-7.2%)
|
35.58B
est: 30.82B (+15.5%)
|
34.94B
est: 36.68B (-4.7%)
|
33.60B
est: 37.16B (-9.6%)
|
32.18B
est: 34.25B (-6.0%)
|
34.02B
33.79B – 34.26B
-0.7% YoY
|
35.56B
35.06B – 36.05B
+4.5% YoY
|
38.01B
37.75B – 38.28B
+6.9% YoY
|
| EBITDA |
2.34B
est: 1.78B (+31.0%)
|
2.04B
est: 1.87B (+9.4%)
|
2.21B
est: 1.78B (+24.2%)
|
2.67B
est: 2.25B (+18.9%)
|
3.39B
est: 2.46B (+37.5%)
|
2.14B
est: 2.60B (-17.7%)
|
3.14B
est: 2.72B (+15.5%)
|
3.16B
est: 2.98B (+5.9%)
|
3.53B
est: 3.67B (-3.8%)
|
2.85B
est: 3.72B (-23.4%)
|
3.40B
est: 3.43B (-1.0%)
|
3.41B
3.38B – 3.43B
-0.7% YoY
|
3.56B
3.51B – 3.61B
+4.5% YoY
|
3.81B
3.78B – 3.83B
+6.9% YoY
|
| EBIT |
1.75B
est: 1.13B (+54.2%)
|
1.42B
est: 1.19B (+19.5%)
|
1.61B
est: 1.13B (+42.8%)
|
1.96B
est: 1.43B (+37.3%)
|
2.35B
est: 1.56B (+50.5%)
|
1.03B
est: 1.65B (-37.8%)
|
2.12B
est: 1.72B (+22.7%)
|
2.14B
est: 1.89B (+12.7%)
|
2.57B
est: 2.48B (+3.4%)
|
1.70B
est: 2.51B (-32.5%)
|
2.37B
est: 2.32B (+2.1%)
|
2.30B
2.29B – 2.32B
-0.7% YoY
|
2.40B
2.37B – 2.44B
+4.5% YoY
|
2.57B
2.55B – 2.59B
+6.9% YoY
|
| Net Income |
1.01B
est: 1.03B (-2.3%)
|
780.00M
est: 800.09M (-2.5%)
|
953.00M
est: 853.90M (+11.6%)
|
993.00M
est: 1.08B (-7.7%)
|
1.29B
est: 1.10B (+17.2%)
|
137.00M
est: 850.25M (-83.9%)
|
1.19B
est: 1.26B (-5.8%)
|
930.00M
est: 1.20B (-22.4%)
|
1.18B
est: 795.82M (+48.0%)
|
-279.00M
est: 553.24M (-150.4%)
|
366.00M
est: 1.29B (-71.6%)
|
1.66B
1.65B – 1.68B
+29.0% YoY
|
2.04B
1.87B – 2.16B
+22.9% YoY
|
2.37B
2.34B – 2.39B
+15.9% YoY
|
| SGA |
4.46B
est: 4.63B (-3.7%)
|
4.70B
est: 4.85B (-3.1%)
|
4.64B
est: 4.61B (+0.6%)
|
5.79B
est: 5.83B (-0.7%)
|
6.27B
est: 6.39B (-1.8%)
|
7.04B
est: 6.75B (+4.3%)
|
6.10B
est: 7.05B (-13.4%)
|
7.80B
est: 7.74B (+0.8%)
|
8.22B
est: 7.07B (+16.3%)
|
9.23B
est: 7.16B (+28.9%)
|
—
est: 6.60B (-100.0%)
|
6.56B
6.51B – 6.60B
-0.7% YoY
|
6.85B
6.76B – 6.95B
+4.5% YoY
|
7.32B
7.27B – 7.37B
+6.9% YoY
|
| EPS |
9.11
est: 9.80 (-7.1%)
|
7.35
est: 7.58 (-3.1%)
|
9.00
est: 8.09 (+11.2%)
|
9.41
est: 10.20 (-7.7%)
|
12.23
est: 10.47 (+16.8%)
|
1.26
est: 8.06 (-84.4%)
|
11.25
est: 11.98 (-6.1%)
|
8.79
est: 11.35 (-22.6%)
|
11.13
est: 7.46 (+49.2%)
|
-2.68
est: 5.19 (-151.7%)
|
3.43
est: 11.97 (-71.3%)
|
15.56
15.42 – 15.70
+30.0% YoY
|
18.88
17.49 – 20.27
+21.3% YoY
|
22.17
21.97 – 22.37
+17.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.09% | 113.3K | 0.42% |
| 2 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.08% | 1.37M | 0.58% |
| 3 | Avantis Emerging Markets Value ETF AVES | 0.05% | 733.0K | 0.36% |
| 4 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.05% | 158.3K | 0.74% |
| 5 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.04% | 164.3K | 0.72% |
| 6 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.04% | 79.9K | 0.33% |
| 7 | Dimensional - Emerging Markets Value ETF DFEV | 0.03% | 666.0K | 0.46% |
| 8 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.03% | 103.8K | 0.56% |
| 9 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.03% | 77.1K | 0.35% |
| 10 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.03% | 168.4K | 0.55% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stuart Miller | Executive Vice President of Mining | 24M | male |
| Ian Kramer | Group Chief Financial Officer & Executive Director | 14M | male |
| Dean K. Murray | Interim CEO, EVP for AECI Chemicals & Director | 12M | male |
| Rafael Fernandes | Chief Transformation Officer | 8M | male |
| Cheryl Singh | Group Company Secretary & General Counsel | 5M | female |
| Chantal Van Dyk | Interim Group Chief People Officer | — | female |
| Itumeleng Lepere | Investor Relations Manager | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AFE.JO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
